Guideline
A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society
[Article in
English,
French]
- PMID: 9039063
Item in Clipboard
Guideline
A position paper on drug-pricing strategies for prescription pharmaceuticals in Canada. Canadian Cardiovascular Society
[Article in
English,
French]
Can J Cardiol.
1997 Jan.
No abstract available
Comment in
-
Reference-based pricing of prescription drugs.Can J Cardiol. 1997 Jan;13(1):31-2. Can J Cardiol. 1997. PMID: 9039062 No abstract available.
-
Reference-based pricing (RBP) of prescription drugs.Can J Cardiol. 1997 Jul;13(7):689-90. Can J Cardiol. 1997. PMID: 9251582 No abstract available.
Similar articles
-
The Canadian Cardiovascular Society and reference-based drug pricing.Can J Cardiol. 1998 May;14(5):669-70. Can J Cardiol. 1998. PMID: 9627521 No abstract available.
-
Coverage of drug costs: reference-based pricing.Can J Cardiol. 1998 May;14(5):666-8. Can J Cardiol. 1998. PMID: 9627520
-
Reference-based pricing of prescription drugs.Can J Cardiol. 1997 Jan;13(1):31-2. Can J Cardiol. 1997. PMID: 9039062 No abstract available.
-
Reference-based pricing in British Columbia: implications for cardiologists--an analysis.Can J Cardiol. 1997 Jan;13(1):46-51. Can J Cardiol. 1997. PMID: 9039064 Review.
-
The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.Nurs Econ. 2005 Nov-Dec;23(6):307-11, 279. Nurs Econ. 2005. PMID: 16459902 Review.
Cited by
-
Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.Pharmacoeconomics. 2002;20(9):577-91. doi: 10.2165/00019053-200220090-00002. Pharmacoeconomics. 2002. PMID: 12141886 Review.
-
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.CMAJ. 2002 Mar 19;166(6):737-45. CMAJ. 2002. PMID: 11944760 Free PMC article.